Lynne Krummen
Corporate Officer/Principal bij VIR BIOTECHNOLOGY, INC.
Profiel
Lynne Krummen is currently working as the Executive VP-Product Development at Vir Biotechnology, Inc. She started this position in 2023.
Prior to her current role, she worked at Genentech, Inc. as the VP & Global Head-Biologics, Regulatory CMC from 2011 to 2018.
Dr. Krummen holds a doctorate degree from The University of Cincinnati College of Medicine.
Actieve functies van Lynne Krummen
| Bedrijven | Functie | Begin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-10-2023 |
Eerdere bekende functies van Lynne Krummen
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van Lynne Krummen
| The University of Cincinnati College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
